Patient Adherence to Glucagon-like Peptide-1 Receptor Agonists – A Hidden Obstacle in Obesity Management

Authors

  • Dr Tahniyah Haq Associate Professor, Dept. of Endocrinology, Bangladesh Medical University, Shahbag, Dhaka, Bangladesh

Keywords:

GLP-1RA,, adherence,, compliance,, discontinuation

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RA) are drugs
intended for the chronic management of obesity. Short-term use
with sudden discontinuation is associated with weight regain and
increased metabolic risk. Despite this, adherence to these medications
is poor. Several factors such as cost and intolerable gastrointestinal side
effects are the cause of poor compliance. This is concerning, especially
in low resource settings. Physicians should keep the possibility of
discontinuation in mind when prescribing these drugs.

Downloads

Published

2025-11-21

Issue

Vol. 2 No. 3 (2025)

Section

From the Global desk

How to Cite

Patient Adherence to Glucagon-like Peptide-1 Receptor Agonists – A Hidden Obstacle in Obesity Management. (2025). Asian Journal Of Obesity, 2(3), 8-9. https://ojs.ijcp.in/index.php/AJO/article/view/1291